Ultrasound opens brain barrier to deliver Parkinson's treatment
NCT ID NCT05565443
Summary
This early-stage study is testing whether focused ultrasound can safely open the blood-brain barrier to deliver an enzyme called GCase directly to the brain in Parkinson's patients. The research involves 14 participants with either genetic or non-genetic Parkinson's who will receive the treatment three times over several weeks. The main goal is to check if this delivery method is safe and feasible, building on animal studies that showed potential benefits for Parkinson's symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSONS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sunybrook Research Institute
RECRUITINGToronto, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.